Eli Lilly reports strong Q2 2025 growth, driven by Mounjaro & Zepbound. Highlights include increased guidance, pipeline updates, and key clinical milestones.

Below are the transcripts from the Q2 earnings call. This transcript is brought to you by Benzinga APIs. For real-time access ...

Key Points Non-GAAP earnings per share reached $0.52 for Q2 2025, beating expectations by $0.01, but revenue (GAAP) fell 4.9% year over year. US sales declined 18.3% (GAAP), leading to a $214 million ...

Guidance for full-year 2025 product revenue and adjusted EBITDA was increased as prescription growth from ADHD drug Jornay PM accelerates, with prescriptions up 23% year-over-year. These 10 stocks ...

TEGNA expects total revenue to decline 18%-20% year over year in Q3 2025 due to the cyclical absence of political and Summer ...

Wayfair sees revenue growth and GAAP profitability in 2025Q2. Learn why the stock upgrade to Hold reflects caution amid ...

Saga Communications, Inc. (Nasdaq - SGA) (the "Company" or "Saga") today reported that net revenue decreased 5.0% to $28.2 million for the ...

Sonos, Inc. SONO reported third-quarter fiscal 2025 non-GAAP earnings per share (EPS) of 19 cents, meeting the Zacks Consensus Estimate. The company reported EPS of 23 cents in the prior-year quarter.

Below are the transcripts from the Q2 earnings call, which took place Thursday morning. This transcript is brought to you by ...

Extreme Networks saw revenue increases last quarter thanks to cloud and subscription growth, as well as growing interest in ...

Amdocs Limited DOX reported better-than-expected third-quarter fiscal 2025 results. The company posted non-GAAP earnings of ...

Operator: Good morning. Welcome to USA Compression Partners Second Quarter 2025 Earnings Conference Call. [Operator ...